Direct Acting Oral Anti-Coagulants for Venous Thromboembolism Prophylaxis after Partial Hip Replacement: Clinical Evidence and Guidelines


( Last Updated : May 11, 2018)
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1220-000

Details


Question


  1. What is the clinical evidence regarding the use of direct-acting anticoagulants for venous thromboembolism prophylaxis following partial hip replacement?

  2. What is the clinical evidence regarding the use of direct-acting anticoagulants for venous thromboembolism prophylaxis following hip fracture repair?

  3. What are the evidence-based guidelines regarding the use of direct-acting anticoagulants for venous thromboembolism prophylaxis following partial hip replacement or hip fracture repair?


Key Message

One systematic review with meta-analysis, three randomized controlled trials, and one non-randomized studies were identified regarding direct-acting oral anti-coagulants for venous thromboembolism prophylaxis after partial hip replacement.